ProfileGDS5822 / ILMN_1240485
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 5% 1% 18% 36% 3% 11% 9% 14% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 17.95
GSM1276600PDAC Late Ablation Control 271
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 110.918
GSM1276603PDAC Late Ablation 217.136
GSM1276604PDAC Late Ablation 34.33
GSM1303940PDAC Late Ablation_anti-CTLA4 19.911
GSM1303941PDAC Late Ablation_anti-CTLA4 26.29
GSM1303942PDAC Late Ablation_anti-CTLA4 38.114